| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |